Position in CCCC
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$65,982
+$27,658 QoQ
Shares Held
14,129
-3.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#113
of 147 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EWA, LLC holds $712,722 across 7 Biotechnology names. CCCC ranks #4 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
492 | $244,391 | |
| 2 | SLS |
SELLAS Life Sciences Group, Inc.
|
12,796 | $188,868 | |
| 3 | CGEN |
Compugen Ltd
|
59,393 | $127,101 | |
| 4 | CCCC |
C4 Therapeutics, Inc.
This page
|
14,129 | $65,982 | |
| 5 | TLSA |
Tiziana Life Sciences Ltd
|
44,692 | $57,205 | |
| 6 | TNYA |
Tenaya Therapeutics, Inc.
|
28,656 | $21,176 | |
| 7 | RANI |
Rani Therapeutics Holdings, Inc.
|
10,520 | $7,999 |
All Filings in CCCC
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,982 | 14,129 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $38,324 | 14,572 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $32,257 | 16,889 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $43,312 | 19,510 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $23,799 | 16,643 | Shares | Sole | 2025-07-18 | |
| No filing history on record for this holder in this stock. | ||||||